Xenetic Biosciences Reports Q2 Net Loss $(1.1)M, Cash Balance of $10.7M
Portfolio Pulse from Benzinga Newsdesk
Xenetic Biosciences reported a net loss of $1.1 million for Q2, with a cash balance of $10.7 million.
August 11, 2023 | 12:13 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Xenetic Biosciences reported a Q2 net loss of $1.1 million. The company's cash balance is $10.7 million.
The reported net loss for Q2 could negatively impact investor sentiment, potentially leading to a decrease in the stock price. The company's cash balance, however, may provide some reassurance to investors about its financial stability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100